• Instagram Icon mit Verlinkung zum Instagram-Auftritt des IfADo's
  • X-Twitter Icon mit Verlinkung zum X.com-Auftritt des IfADo's
  • Instagram Icon mit Verlinkung zum Facebook-Auftritt des IfADo's
  • YouTube Icon mit Verlinkung zum YouTube-Kanal des IfADo's
  • LinkedIn Icon mit Verlinkung zum LinkedIn-Auftritt des IfADo's
  • Mastodon Icon mit Verlinkung zum Mastodon-Auftritt des IfADo's
Leitung
Prof. Dr. Jan G. Hengstler
Anschrift
Ardeystr. 67
44139 Dortmund

Publikationen Toxikologie

Hernández AF, Jeddi MZ, Wilks MF, FitzGerald R, Duca RC, Villeneuve D, Viegas S, Hotta A, Baucher MA, Browne P, Scholten B, Simon E, Poddalgoda D, Bal-Price A, Mustieles V, van Thriel C, Bonassi S, Fenech M, Ndaw S, Pieper C, Rissler J, Paini A, Farcal L, Schmid K, Pasanen-Kase R, Hopf NB:
Using effect biomarker thresholds in regulatory risk assessment: an OECD-based framework for assessing cumulative exposures to chemical mixtures. Environ Int 211: 110215 (2026) doi: 10.1016/j.envint.2026.110215
Batke M, Damm G, Foth H, Freyberger A, Hengstler JG, Mangerich A, Mielke H, Partosch F, Schupp T, Sonnenburg A, Vom Brocke J, Wollin KM, Algharably EA, Gundert-Remy U:
A tool to assess the internal validity of toxicokinetic studies. Arch Toxicol (2026) doi: 10.1007/s00204-026-04387-y
van Kesteren PCE, van Berlo D, Bard D, Butler O, Dekkers S, Hadrup N, Lovén K, Riediker M, Schins RPF, van Thriel C, Vogel U, Gosens I:
Health-based nanomaterial guidance value (HNGV) for occupational exposure to spheroidal biodurable engineered nanomaterials of relatively low substance-specific toxicity. NanoImpact 42: 100621 (2026) doi: 10.1016/j.impact.2026.100621
Niegisch G, Gakis G, Ohlmann CH, Knüchel-Clarke R, Beyersdorff D, Rick O, Golka K, Hegemann M, Goebell PJ, Maisch P, Gschwend J:
Leitlinie „Harnblasenkarzinom“ – was gibt es Neues? [Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]. Urologie·65: 490–497 (2026) doi: 10.1007/s00120-026-02810-x
Adesida SO, Oyetunji RA, Alimba CG:
Bioactive Compounds from Edible Mushrooms as Pharmaceutical Ingredients: A Comprehensive Review of the Developmental Pipeline. Processes 14(5): 795 (2026) doi: 10.3390/pr14050795
Alwahsh M, Abusara OH, Zaid AA, Hasan A, Hamadneh L, Marchan R:
Synergistic cytotoxic effect of doxorubicin and bortezomib on lung cancer cell lines using 2D and 3D models. Cancer Treat Res Commun 47: 101133 (2026) doi: 10.1016/j.ctarc.2026.101133
Lampen A, Lachenmeier DW, Diel P, Ensenauer R, Frommherz L, Guth S, Humpf HU, Kulling SE, Villar-Fernández MA, Wätjen W, Mally A, Steinberg P:
Dietary phosphate exposure–strategies to protect vulnerable population groups. Arch Toxicol 100: 1657–1684 (2026) doi: 10.1007/s00204-025-04274-y
Heij L, Hayat S, Reichel K, Maryam S, O'Rourke CJ, Tan X, van den Braber M, Verhoeff J, Halder M, Peisker F, Wiltberger G, Bednarsch J, Heise D, Deierl JC, Lang SA, Ulmer F, Luedde T, Dahl E, Jonigk D, Nolting J, Sivakumar S, Siveke J, Vondran F, Rocha FG, Baba HA, Hartmann S, Andersen JB, Hobloss Z, Ghallab A, Hengstler JG, Vallejo JJG, Kramann R, Neumann U:
Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients. NPJ Precis Oncol 10: 105 (2026) doi: 10.1038/s41698-026-01292-6
Zhou P, Hammour MM, Aspera-Werz RH, Ehnert S, Myllys M, Hobloss Z, Hassan R, González D, Hendawi R, Edlund K, Hans S, Laschke MW, Ghallab A, Hengstler JG, Nüssler AK, Maisenbacher TC:
Long-term Western diet feeding impairs hepatic vitamin D metabolism and promotes bone loss in mice. EXCLI J 25: 290-309 (2026) doi: 10.17179/excli2025-9085
Roth A, Franz CMAP, Hertwig S, Holzhauser T, Hertel C, Humpf HU, Engel KH, Schwarzenbolz U, Schlüter O, Jäger H, Aganovic K, Heinz V:
Limitations and safety aspects related to the use of bacteriophages in food production. FEMS Microbiol Rev 50: fuag002 (2026) doi: 10.1093/femsre/fuag002